Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjun Yu

Showing results (361-370 of 421) with videos related to

Pageof 43
Sort By:
BMC Medicine|September 5, 2024
Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinomaMiaoyan Wei, Rujiao Liu, Yunyun Xu, et al.
Oncology Letters|November 23, 2017
Carbohydrate antigen 19-9 as a prognostic biomarker in pancreatic neuroendocrine tumorsGuopei Luo, Kaizhou Jin, He Cheng, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 15, 2017
Revised nodal stage for pancreatic neuroendocrine tumorsGuopei Luo, Kaizhou Jin, He Cheng, et al.
Acta Biochimica Et Biophysica Sinica|September 22, 2016
Energy sources identify metabolic phenotypes in pancreatic cancerChen Liang, Yi Qin, Bo Zhang, et al.
BMC Medicine|April 14, 2025
Correction: Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinomaMiaoyan Wei, Rujiao Liu, Yunyun Xu, et al.
BMJ Open|April 5, 2022
Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre randomised controlled trialShutao Pan, Tingting Qin, Taoyuan Yin, et al.
Cancer Science|June 3, 2021
Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancerDan-Hua He, Yu-Fei Chen, Yi-Le Zhou, et al.
Cancer Letters|January 28, 2014
Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, ChinaJiang Long, Guo-pei Luo, Zhi-wen Xiao, et al.
Acta Biochimica Et Biophysica Sinica|January 5, 2023
MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumorsZeng Ye, Haidi Chen, Shunrong Ji, et al.
Oncogene|June 5, 2025
Small extracellular vesicle-miR-183-5p mediated crosstalk between tumor cells and macrophages in high-risk pancreatic neuroendocrine tumorsWuhu Zhang, Junfeng Xu, Dan Huang, et al.
Pageof 43

Showing results (361-370 of 421) with videos related to

Sort By:
Pageof 43
BMC Medicine|September 5, 2024
Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinomaMiaoyan Wei, Rujiao Liu, Yunyun Xu, et al.
Oncology Letters|November 23, 2017
Carbohydrate antigen 19-9 as a prognostic biomarker in pancreatic neuroendocrine tumorsGuopei Luo, Kaizhou Jin, He Cheng, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 15, 2017
Revised nodal stage for pancreatic neuroendocrine tumorsGuopei Luo, Kaizhou Jin, He Cheng, et al.
Acta Biochimica Et Biophysica Sinica|September 22, 2016
Energy sources identify metabolic phenotypes in pancreatic cancerChen Liang, Yi Qin, Bo Zhang, et al.
BMC Medicine|April 14, 2025
Correction: Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinomaMiaoyan Wei, Rujiao Liu, Yunyun Xu, et al.
BMJ Open|April 5, 2022
Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre randomised controlled trialShutao Pan, Tingting Qin, Taoyuan Yin, et al.
Cancer Science|June 3, 2021
Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancerDan-Hua He, Yu-Fei Chen, Yi-Le Zhou, et al.
Cancer Letters|January 28, 2014
Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, ChinaJiang Long, Guo-pei Luo, Zhi-wen Xiao, et al.
Acta Biochimica Et Biophysica Sinica|January 5, 2023
MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumorsZeng Ye, Haidi Chen, Shunrong Ji, et al.
Oncogene|June 5, 2025
Small extracellular vesicle-miR-183-5p mediated crosstalk between tumor cells and macrophages in high-risk pancreatic neuroendocrine tumorsWuhu Zhang, Junfeng Xu, Dan Huang, et al.
Pageof 43